Author

Elizabeth Titova

Observed name: E.А. Тitova

Institution: Hackensack Meridian Health

Observed institution: Hackensack Meridian Health

ORCID: 0000-0001-7136-7828

Observed ORCID: 0000-0001-7136-7828

OpenAlex ID: A5000349753

Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern

2022 · Devendra K. Rai, Irina Yurgelonis, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 35

Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey

2023 · José R. Mediavilla, Tara Lozy, et al. · Viruses · 7

Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations

2024 · Elizabeth Titova, Veronica W. Kan, et al. · Microbiology Spectrum · 6

Analysis of ibuzatrelvir's activity against SARS-CoV-2 circulating variants and in vitro resistance mutations

2026 · Irina Yurgelonis, Devendra K. Rai, et al. · Antiviral Research · 3

Immunocompetent and immunocompromised cancer populations: Post-vaccination humoral and cellular immune responses against SARS-CoV-2.

2023 · Elizabeth Titova, Veronica W Kan, et al. · Journal of Clinical Oncology · 1

Antiviral activity of nirmatrelvir against contemporary SARS-CoV-2 variants

2026 · Irina Yurgelonis, Devendra K. Rai, et al. · Antiviral Research

Fluoroquinolone-Resistant Enterobacteriaceae Prevalence for Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (aHSCT) in the Treatment of Multiple Myeloma (MM)

2023 · Elizabeth Titova, Scott Rowley, et al. · Blood

Changes of clinical pharmacokinetics of pharmaceutical substances during pregnancy

2018 · Yu.V. Volkova, Z.А. Тitova, et al. · Voprosy ginekologii akušerstva i perinatologii

Works count: 8

Citation count: 52

H-index: 3

I10-index: 1